KYMR
Price
$30.13
Change
-$1.31 (-4.17%)
Updated
May 21 closing price
Capitalization
2.05B
71 days until earnings call
OMER
Price
$3.11
Change
-$0.18 (-5.47%)
Updated
May 21 closing price
Capitalization
182.22M
76 days until earnings call
Interact to see
Advertisement

KYMR vs OMER

Header iconKYMR vs OMER Comparison
Open Charts KYMR vs OMERBanner chart's image
Kymera Therapeutics
Price$30.13
Change-$1.31 (-4.17%)
Volume$572.98K
Capitalization2.05B
Omeros
Price$3.11
Change-$0.18 (-5.47%)
Volume$1.01M
Capitalization182.22M
KYMR vs OMER Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. OMER commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and OMER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (KYMR: $30.13 vs. OMER: $3.11)
Brand notoriety: KYMR and OMER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 82% vs. OMER: 96%
Market capitalization -- KYMR: $2.05B vs. OMER: $182.22M
KYMR [@Biotechnology] is valued at $2.05B. OMER’s [@Biotechnology] market capitalization is $182.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileOMER’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • OMER’s FA Score: 0 green, 5 red.
According to our system of comparison, OMER is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while OMER’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • OMER’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than OMER.

Price Growth

KYMR (@Biotechnology) experienced а +1.28% price change this week, while OMER (@Biotechnology) price change was -20.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

OMER is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.05B) has a higher market cap than OMER($182M). KYMR YTD gains are higher at: -25.106 vs. OMER (-68.522). OMER has higher annual earnings (EBITDA): -155.96M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. OMER (123M). KYMR has less debt than OMER: KYMR (86.3M) vs OMER (209M). KYMR has higher revenues than OMER: KYMR (58.9M) vs OMER (0).
KYMROMERKYMR / OMER
Capitalization2.05B182M1,125%
EBITDA-232.67M-155.96M149%
Gain YTD-25.106-68.52237%
P/E RatioN/AN/A-
Revenue58.9M0-
Total Cash463M123M376%
Total Debt86.3M209M41%
FUNDAMENTALS RATINGS
OMER: Fundamental Ratings
OMER
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMROMER
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 27 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APWIX12.29N/A
N/A
AB Sustainable Thematic Bal Port I
JLPSX21.10N/A
N/A
JPMorgan US Large Cap Core Plus I
LBSCX32.82N/A
N/A
Columbia Dividend Income C
ABMIX22.61N/A
N/A
AMG River Road Mid Cap Value I
PABFX17.82N/A
N/A
PGIM Balanced Z